Therapy Areas: Allergy
30 September 2026 - Late-stage biopharmaceutical company DBV Technologies (Euronext:DBV) (Nasdaq:DBVT) announced on Wednesday that it has submitted a Biologics License Application to the US Food and D...
9 June 2026 - Argo Biopharmaceutical Co., Ltd., a China-based, clinical-stage small interfering RNA (siRNA) therapeutics company, announced on Monday that it has been selected to present Phase II upda...
4 March 2026 - Biotechnology company Allergy Therapeutics plc (AIM: AGY) on Wednesday reported positive biomarker results from its Phase I/IIa PROTECT trial of VLP Peanut, following the achievement of...
26 February 2026 - Argo Biopharmaceutical Co Ltd, a China-based, clinical-stage small interfering RNA (siRNA) therapeutics company, announced on Wednesday that it has been selected as a late breaking ...